Short communication: CD4 counts of HIV‐infected pregnant women and their infected children – implications for PMTCT and treatment programmes

Abstract
A considerable proportion of pregnant women and their infected children are likely to be eligible for anti-retroviral treatment. The antenatal-postnatal divide needs to be bridged with respect to the follow-up of both HIV-infected women and their exposed infants.